Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis

Thrombosis Research(2021)10.1016/j.thromres.2021.04.009Source: DataRank Database

Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis is a research paper published in Thrombosis Research (2021). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)Impact (FWCI 0.56)OA: bronzeTopics (44)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Rebecca L. Zon ORCID,Katelyn W. Sylvester ORCID,Jessica Rimsans ORCID,Evan C. Chen ORCID,Auyon Ghosh ORCID

Live enrichment

PubMed:33940309 OpenAlex:https://openalex.org/W3155086307

National Institutes of Health

Grant: U01 HL089897

National Institutes of Health

Grant: T32HL007427

National Institutes of Health

Grant: U01 HL089856

National Institutes of Health

Grant: K08HL136928

National Institutes of Health

Grant: R01 HL089856

National Institutes of Health

Grant: R01HL135142

National Institutes of Health

Grant: R01HL137927

National Institutes of Health

Grant: 5R01HL135142-04

Genetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung Abnormalities

National Institutes of Health

Grant: 5T32HL007427-27

Clinical Epidemiology of Lung Diseases

National Institutes of Health

Grant: 5K08HL136928-04

Multi-omic Subtyping of Chronic Obstructive Pulmonary Disease

National Institutes of Health

Grant: 1U01HL089856-01A1

Genetic Epidemiology of COPD

National Institutes of Health

Grant: 5U01HL089897-13

(1 of 2) Genetic Epidemiology of COPD

National Institutes of Health

Grant: 5R01HL137927-02

Identifying functional variants in COPD GWAS loci

FWCI

0.56

Citation Percentile

0.7%

Citation Trend

2021

2022

bronzeLicense: Elsevier TDM

journalhttp://www.thrombosisresearch.com/article/S0049384821002942/pdf

publisherhttp://www.thrombosisresearch.com/article/S0049384821002942/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0049384821002942?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0049384821002942?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.thromres.2021.04.009

Fields of Study

COVID-19 Clinical Research StudiesVenous Thromboembolism Diagnosis and ManagementCOVID-19 and healthcare impacts03 medical and health sciences0302 clinical medicineAnticoagulantsCOVID-19HeparinHumansIntensive Care UnitsPropensity ScoreRetrospective StudiesSARS-CoV-2

MeSH Terms

COVID-19SARS-CoV-2AnticoagulantsHeparinHumansIntensive Care UnitsRetrospective StudiesPropensity Score

Keywords

MedicinePropensity score matchingCoronavirus disease 2019 (COVID-19)HeparinIncidence (geometry)Internal medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)AnesthesiaDiseasePathologyInfectious disease (medical specialty)Intensive Care UnitsSARS-CoV-2Letter to the Editors-in-ChiefAnticoagulantsCOVID-19HumansPropensity ScoreRetrospective StudiesAnticoagulationCritical careIntermediate dose

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being